Virtus Investment Advisers, Inc. Adma Biologics, Inc. Transaction History
Virtus Investment Advisers, Inc.
- $286 Million
- Q2 2025
A detailed history of Virtus Investment Advisers, Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Virtus Investment Advisers, Inc. holds 20,574 shares of ADMA stock, worth $344,820. This represents 0.13% of its overall portfolio holdings.
Number of Shares
20,574
Previous 19,230
6.99%
Holding current value
$344,820
Previous $381,000
1.84%
% of portfolio
0.13%
Previous 0.13%
Shares
7 transactions
Others Institutions Holding ADMA
# of Institutions
396Shares Held
196MCall Options Held
2.53MPut Options Held
746K-
Vanguard Group Inc Valley Forge, PA21.4MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$312 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$216 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$192 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$99.1 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.29B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...